1 The safety profile of RADICAVA ORS was generally consistent across age, race, & gender 1 No overall differences in safety or effectiveness of RADICAVA ORS were observed between geriatric patients over the age of 65 and younger patients, but greater sensitivity of some older individuals cannot be ruled out 1 Low rate of discontinuations due to adverse events (AEs) 3 Only 4 patients discontinued treatment in the first 2 months (4/185)
No Artificial Colors No Artificial Flavors No Preservatives No Yeast, Starch or Gluten *These statements have not been evaluated by the Food and Drug Administration
PDA The primary difference lies in the addition of the arginine salt form to create Pentadeca Arginate
Ipamorelin is a selective growth hormone secretagogue that acts on the ghrelin receptor (GHSR-1a)
Elsevier eBooks
World J Gastroenterol 25(16):1907 Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
